Monday, 8th September 2008 |
08:30
17:00 |
Patient Interest Group |
18:00 |
Welcome Reception in the Konzil Building |
|
Tuesday, 9th September 2008 |
08:15
09:15 |
1st Scientific SessionSymposium: Infectious Uveitis
Chairmen: Khalid Tabbara (Riyadh, Saudi Arabia)
Rubens Belfort Jr. (Sao Paulo, Brazil) |
01 |
Justus G. Garweg (Bern, Switzerland) Toxoplasmic Uveitis |
02 |
Khalid Tabbara (Riyadh, Saudi Arabia) Ocular Infections following solid Organ Transplantation |
03 |
Sivakumar R. Rathinam (Madurai, India) Problems with Uveitis in developing Countries |
04 |
Denis Wakefield (Sydney, Australia) Infection and Autoimmunity |
|
Round Table |
09:15
09:30 |
Coffee Break |
09:30
10:45 |
2nd Scientific SessionSymposium of the Society for Ocular Immunoinfectiology in Europe (SOIE) - Diagnosis and Assessment of Uveitis: Update and Problems
Chairmen: Carl P. Herbort (Lausanne, Switzerland)
Manabu Mochizuki (Tokyo, Japan) |
05 |
Manabu Mochizuki (Tokyo, Japan) Progress in the Nomenclature of ocular Sarcoidosis |
06 |
Carl P. Herbort (Lausanne, Switzerland) Diagnosis and Assessment of choroidal Inflammation using appropriate investigational Technology |
07 |
Ilknur Tugal-Tutkun (Istanbul, Turkey) Non invasive Assessment and follow-up of inflammatory Activity in Behçet's Uveitis using Laser flare Photometry |
08 |
Friederike Mackensen1, F. David1, V. Schwenger1, R. Levinson3,R. Rajalingam3, M.D. Becker1, T.M. Martin2, J.T. Rosenbaum2 (1Heidelberg, Germany, 2Portland, USA, 3Los Angeles, USA) Developments in diagnosing the tubulointerstitial Nephritis and Uveitis (TINU) Syndrome |
09 |
Moncef Khairallah (Monastir, Tunesia) Diagnosis of infectious Uveitis caused by emerging Agents |
09 |
Discussion |
10:45
10:50 |
Coffee Break |
10:50
12:20 |
Opening Ceremony |
|
Welcome and Opening Address Manfred Zierhut (Tuebingen, Germany) |
|
Opening Addresses of the Presidents of the participating ocular Inflammation Societies:
Philip I. Murray (Birmingham, UK) IUSG
Janet L. Davis (Miami, USA) AUS
Carl P. Herbort (Lausanne, Switzerland) SOIE
Phuc LeHoang (Paris, France) IOIS |
|
Opening Address of the Uveitis Patient Interest Group Phil Hibbert (Vidlin, UK) |
|
IUSG: 30th Anniversary Shigeaki Ohno (Sapporo, Japan) |
|
IUSG Eye Fund Gold Medal: Introduction Khalid Tabbara (Riyadh, Saudi Arabia) |
10 |
Global Challenges in Diagnosis and Management of Tuberculous Uveitis in 21st Century Narsing A. Rao (Los Angeles, USA) |
|
Presentation of the Medal Jean-Paul Dernouchamps (Brussels, Belgium) |
|
T. F. Schlaegel, Jr.-G. R. O'Connor Medal: Introduction K. Matti Saari (Turku, Finland) |
|
Presentation of the Medal K. Matti Saari (Turku, Finland) Philip I. Murray (Birmingham, UK) |
12:20
13:15 |
Lunch |
13:15
14:15 |
Uveitis-Award Ceremony
supported by
|
11 |
Friederike Mackensen (Heidelberg, Germany) Enhanced Recognition, Treatment and Prognosis of Tubulointerstitial Nephritis and Uveitis Syndrome |
12 |
Deshka Doycheva (Tuebingen, Germany) High Incidence of Antibodies to Lens Proteins in Sera from Patients with Uveitis |
13 |
Yvonne de Kozak (Paris, France) Protein Kinase Cz (PKCz) regulates ocular Inflammation and Apoptosis in Endotoxin-induced Uveitis (EIU): signaling Molecules involved in EIU Resolution by PKCz Inhibitor and Interleukin-13 |
14 |
Debra A. Goldstein (Chicago, USA) Intraocular Pressure in Patients with Uveitis treated with Fluocinolone Acetonide Implants |
15 |
Teresa Lambe, John V. Forrester (Aberdeen, UK) Limited peripheral T cell Anergy predisposes to retinal Autoimmunity |
16 |
Johannes C. Milikan (Rotterdam, The Netherlands) Identification of viral Antigens recognized by ocular infiltrating T Cells from Patients with Varicella Zoster Virus-induced Uveitis |
17 |
Ahjuko Amadi-Obi, Cheng-Rong Yu (Bethesda, USA) TH 17 Cells contribute to Uveitis and Scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 |
14:30
15:45 |
3rd Scientific SessionSymposium: OCT
Chairmen: Marc D. de Smet (Amsterdam, The Netherlands)
Cristina Muccioli (Sao Paulo, Brazil)
supported by
|
18 |
Miriam van Velthoven (Amsterdam, The Netherlands) OCT: Interpretative Pearls and Pitfalls |
19 |
Richard B. Rosen1, Marc D. de Smet2,3 (1New York, USA, 2Amsterdam, The Netherlands, 3Antwerp, Belgium) What OCT can offer in the Future |
20 |
Cristina Muccioli (Sao Paulo, Brazil) When and where is OCT useful in Uveitis? |
21 |
Marc D. de Smet1,2, T.H.C. Tran3, P. LeHoang4 (1Amsterdam, The Netherlands, 2Antwerp, Belgium, 3Lille, France, 4Paris, France) Uveitic macular Edema: OCT Classification and Outcomes |
|
Round Table |
15:45
16:00 |
Coffee Break |
16:00
17:00 |
4th Scientific SessionSymposium: Tuberculosis and Uveitis
Chairmen: Narsing A. Rao (Los Angeles, USA)
Manfred Zierhut (Tuebingen, Germany) |
22 |
Amod Gupta, R. Bansal, V. Gupta, P. Bambery, A. Sharma (Chandigarh, India) Diagnostic Criteria of intraocular Tuberculosis |
23 |
Luca Cimino1, M. Losi2, L. Richeldi2, L. Cappuccini1 (1Reggio Emilia, Italy, 2Modena, Italy) Role of gamma-Interferon Tests for the Management of presumed tuberculous intraocular Inflammation |
24 |
Manfred Zierhut (Tuebingen, Germany) Latent Tuberculosis and Uveitis |
25 |
Thomas Albini, P. Karakousis, N. A. Rao (Miami, USA) Pathogenesis of intraocular Tuberculosis |
17:00
17:15 |
Coffee Break |
17:15
18:30 |
5th Scientific SessionFree Papers 1 - Clinical and Experimental Uveitis
Chairmen: Jean-Paul Dernouchamps (Brussels, Belgium)
Howard Tessler (Gurnee, USA) |
26 |
Ilknur Tugal-Tutkun, M. Taskapili, Y. A. Akova (Istanbul, Turkey) Bilateral acute Depigmentation of the Iris (BADI): Report on 24 new Cases and long-term follow-up of 2 Patients |
27 |
Jyotirmay Biswas, S. Sudharshan, S. Shrikrishnan, S. Kaleemunnisha, N. Kumarasamy (Chennai, India) Ocular Lesions in 1000 consecutive HIV positive Patients in India - A Study of 15 Years (1993-2008) |
28 |
Eva Angermair, D. Doycheva, N. Stübiger, C.M.E. Deuter, E. Altpeter, S. Biester, M. Zierhut (Tuebingen, Germany) Jabs-Blau Syndrome in a Family of five Generations |
29 |
Nobuyoshi Kitaichi, A. Miyazaki, D. Iwata, K. Namba, M. Stanford, H. Shams, S. Ohno (Sapporo, Japan) An international Survey on Behçet's Disease with ocular Lesions in Children |
30 |
Peizeng Yang (Chongquing, China) Decreased Frequency and diminished Function of CD4+CD25 high regulatory T Cells are associated with active Uveitis in Patients with Vogt-Koyanagi-Harada Disease |
31 |
Ahmed Abu El-Asrar1, S. Struyf2, J. Van Damme2, K. Geboes2 (1Riyadh, Saudi Arabia, 2Leuven, Belgium) Circulating Fibrocytes contribute to the Myofibroblast Population in proliferative Vitreoretinopathy epiretinal Membranes |
32 |
François Willermain, E. Motulsky, S. Janssens, P. Koch, M. Lienart, A.-M. Vanbellinghen, M.-D. Martin-Martinez, L. Caspers, C. Delporte (Brussels, Belgium) Aquaporin Expression on Blood retinal Barrier Cells during experimental autoimmune Uveitis |
|
End of session |
|
Wednesday, 10th September 2008 |
08:15
09:15 |
6th Scientific SessionSymposium: Cystoid Macular Edema (CME)
Chairmen: Aniki Rothova (Utrecht, The Netherlands)
Alan H. Friedman (New York, USA)
supported by
|
33 |
Justus G. GarwegJohn Marshall (London, UK) Pathophysiology of CME |
34 |
Khalid TabbaraAniki Rothova (Utrecht, The Netherlands) Visual Impact of CME in Uveitis |
35 |
Sivakumar R. RathinamAhmed Abu El-Asrar (Riyadh, Saudi Arabia) Diagnostic Methods and their Relevance |
36 |
Denis WakefieldElizabeth M. Graham (London, UK) CME in Children |
37 |
Annabelle A. Okada (Tokyo, Japan) Treatment Strategies for CME |
38 |
Tom Missotten, G.S. Baarsma, J.A.M. van Laar, P.L.A. van Daele, T. van der Loos, R.W. Kuijpers, P.M. van Hagen (Rotterdam, The Netherlands) Biologicals and Somatostatin Analogues in the Treatment of uveitic CME |
39 |
The T. F. Schlaegel, Jr.-G. R. O'Connor Medal lecture: Rubens Belfort Jr. (Sao Paulo, Brazil) Surgical modalities for CME: From PPV to Implants |
09:45
10:00 |
Coffee Break |
10:00
11:15 |
7th Scientific SessionSymposium: JIA associated Uveitis
Chairmen: Arnd Heiligenhaus (Muenster, Germany)
Elizabeth M. Graham (London, UK)
supported by
|
40 |
Traudel K. Saurenmann (Zurich, Switzerland) JIA Uveitis: Epidemiology and Screening |
41 |
Elizabeth M. Graham (London, UK) JIA Uveitis: Complications, visual Outcome and Outcome Predictors |
42 |
Michael Frosch (Muenster, Germany) Pathogenesis of Juvenile Idiopathic Arthritis |
43 |
Joke H. de Boer (Utrecht, The Netherlands) Pathophysiology of JIA associated Uveitis |
44 |
Arnd Heiligenhaus (Muenster, Germany) Immunosuppression in JIA associated Uveitis |
45 |
Manfred Zierhut (Tuebingen, Germany) TNF-alpha blocking Agents in JIA associated Uveitis |
|
Round Table |
11:15
11:20 |
Coffee Break |
11:20
12:20 |
8th Scientific SessionPoster Session 1 - Clinical Uveitis
Chairmen: Philippe Kestelyn (Gent/Belgium)
Ahmed Abu El-Asrar (Riyadh, Saudi Arabia) |
46 |
Howard Tessler, D. A. Goldstein (Gurnee, USA) Etiology of chronic Iridocyclitis over 34 Years Poster no. p1 |
47 |
Petja Vassileva, T. Hergeldzhieva (Sofia, Bulgaria) Diagnostic and therapeutic Problems in herpetic Keratouveitis Poster no. p6 |
48 |
Jan Kunkel, D. Schürmann, U. Pleyer, K. Rüther, C. Kneifel, L. Krause, M. Reichert, R. Ignatius, T. Schneider (Berlin, Germany) Ocular Syphilis - an Indicator of previously unknown HIV-Infection Poster no. p8 |
49 |
Christos Kalogeropoulos1, M. Stefaniotou1, A. Mentis2 (1Ioannina, Greece, 2Athens, Greece) Bartonella and intraocular Inflammation Poster no. p7 |
50 |
Padmamalini Mahendradas, R. Shetty, K. Bhujang Shetty (Bangalore, India) Chikungunya Retinitis Poster no. p21 |
51 |
Amod Gupta, V. Gupta, P. Gupta, A. Sharma (Chandigarh, India) 'Choroidal Folds' in acute Stage of Vogt-Koyanagi-Harada Disease represent the Troughs of elevated retinal Pigment Epithelium Poster no. p29 |
52 |
Thomas Ness, N. Feltgen, H. Agostini, D. Böhringer, B. Lubrich (Freiburg, Germany) Toxic Vitritis and toxic anterior Segment Syndrome following intravitreal Bevacizumab Injection Poster no. p35 |
12:20
13:15 |
Lunch |
13:15
14:30 |
9th Scientific SessionSymposium: HLA-B27 associated Uveitis
Chairmen: Denis Wakefield (Sydney, Australia)
K. Matti Saari (Turku, Finland)
supported by
|
53 |
Denis Wakefield (Sydney, Australia) What is new in HLA-B27 associated Uveitis? |
54 |
Juergen Braun (Herne, Germany) Pathology and Pathogenesis of ankylosing Spondylitis |
55 |
Shigeaki Ohno (Sapporo, Japan) Genes and anterior Uveitis: Are there more Associations than HLA-B27? |
56 |
Nikos Markomichelakis (Athens, Greece) Update on Treatment of HLA-B27 associated Uveitis |
|
Round Table |
14:30
14:45 |
Coffee Break |
16:00
17:00 |
10th Scientific SessionSymposium: Viral Disorders and Uveitis
Chairmen: Bahram Bodaghi (Paris, France)
Soon Phaik Chee (Singapore)
supported by
|
57 |
Bahram Bodaghi (Paris, France) Keynote Lecture: Update on antiviral Therapy |
58 |
Lenneke de Visser (Utrecht, The Netherlands) Laboratory Diagnosis of viral Uveitis |
59 |
Howard Tessler (Gurnee, USA) Fuchs Uveitis: Rubella versus other Viruses |
60 |
Soon Phaik Chee (Singapore) CMV induced anterior Uveitis |
61 |
Janet L. Davis (Miami, USA) Viral Infection of the posterior Segment |
|
Round Table |
16:00
16:15 |
Coffee Break |
17:15
18:30 |
11th Scientific SessionSymposium of the International Ocular Inflammation Society (IOIS) - Behçet's Disease
Chairmen: Ilknur Tugal-Tutkun (Istanbul, Turkey)
Shigeaki Ohno (Sapporo,Japan)
supported by
|
62 |
Phuc LeHoang (President of the IOIS) Introduction |
63 |
Shigeaki Ohno, N. Kitaichi, H. Kitamei, K. Namba, A. Miyazaki, D. Iwata (Sapporo, Japan) Epidemiology of Behçet's Disease in the Year 2008 |
64 |
Ahmet Gul (Istanbul, Turkey) Recent Progress in Understanding the Etiopathogenesis of Behçet's Disease |
65 |
Ilknur Tugal-Tutkun (Istanbul, Turkey) What is Behçet's Disease? Could we diagnose the Disease in the Absence of extraocular Manifestations? |
66 |
Bahram Bodaghi (Paris, France) Management of Behçet Uveitis |
|
Round Table
Massimo Accorinti (Rome, Italy)
Ahmed Abu El-Asrar (Riyadh, Saudi Arabia)
Martin van Hagen (Rotterdam, The Netherlands)
Moncef Khairallah (Monastir, Tunesia)
Manabu Mochizuki (Tokyo, Japan)
Robert B. Nussenblatt (Bethesda, USA)
Khalid Tabbara (Riyadh, Saudi Arabia)
Manfred Zierhut (Tuebingen, Germany) |
|
End of session |
19:00 |
Boat Trip on Lake Constance Boarding on the Lakeside of the Konzil |
|
Thursday, 11th September 2008 |
08:15
09:15 |
12th Scientific SessionSymposium: Surgery and Uveitis
Chairmen: Carlos E. Pavesio (London, UK)
Matthias Becker (Zurich, Switzerland)
supported by
|
67 |
Carlos E. Pavesio (London, UK) How to best handle uveitic Cataracts |
68 |
Matthias Becker (Zurich, Switzerland) Role of Vitrectomy in the Therapy of Uveitis |
69 |
Fokke Ziemssen, F. Gelisken, W. Inhoffen, M. Völcker, M. Zierhut (Tuebingen, Germany) Role of anti-VEGF Treatment of CNV in Uveitis |
70 |
Laure Caspers (Brussels, Belgium) Laser in Uveitis |
|
Round Table |
09:30
09:45 |
Coffee Break |
09:45
11:15 |
13th Scientific SessionSymposium: Secondary Glaucoma and Uveitis
Chairmen: Philip I. Murray (Birmingham, UK)
Elke Luetjen-Drecoll (Erlangen, Germany)
supported by
|
71 |
Philip I. Murray (Birmingham, UK) Pathophysiology of Glaucoma in Uveitis |
72 |
Elke Luetjen-Drecoll (Erlangen, Germany) Keynote Lecture: Steroid induced Glaucoma |
73 |
Tom Missotten, P. McCluskey, J.H. Chang, P. Ferrante, B. Jalaludin, S. Lightman (Rotterdam, The Netherlands) Use of ocular hypotensive Prostaglandin Analogues in Patients with Uveitis |
74 |
Peter Shah (Birmingham, UK) Trabeculectomy in Uveitis |
75 |
Philippe Kestelyn (Ghent, Belgium) Non perforating deep Sclerectomy (NPDS) in Uveitis Patients |
|
Round Table |
11:15
11:20 |
Coffee Break |
11:20
12:20 |
14th Scientific SessionPoster Session 2 - Diagnostic and Experimental Uveitis
Chairmen: Douglas A. Jabs (New York, USA)
Peizeng Yang (Chongquing, China) |
76 |
Hatice Nida Sen, A. Sangave, D. Goldstein, E. Suhler, S. Vitale, R.B. Nussenblatt (Bethesda, USA) Scleritis grading System (SGS): Standardization of scleral inflammatory Activity Poster no. p37 |
77 |
Deshka Doycheva, C.M.E. Deuter, C. Pfannenberg, V. Kempf, E. Schuelen, J. Hetzel, M. Zierhut (Tuebingen, Germany) PET-CT as a new diagnostic Method in Uveitis Poster no. p47 |
78 |
Anita Chan, S.P. Chee (Singapore) Cytomegalovirus (CMV) Retinitis in immunocompetent Eyes: Detection of a novel CMV DNA Polymerase (UL54) Gene Mutation Poster no. p50 |
79 |
Friederike Mackensen, U. Wiehler, R. Max, A. Dalpke, S. Zimmermann, M.D. Becker (Heidelberg, Germany) QuantiFERON TB-Gold - A new Test strengthening long suspected tuberculous Involvement in serpiginous-like Chorioiditis Poster no. p42 |
80 |
Jamie Yuxin Ng, S.L. Ho, L.W. Heng (Singapore) The Use of Tetraplex Polymerase Chain Reaction (PCR) Analysis in Uveitis in Singapore Poster no. p51 |
81 |
Lia Judice M. Relvas, C. Bouffioux, B. Marcet, D. Communi, M. Makhoul, M. Horckmans, D. Blero, C. Bruyns, L. Caspers, J.M. Boeynaems, F. Willermain (Brussels, Belgium) Extracellular Nucleotides stimulate Interleukin-8 Production by ARPE Cells: potential Role of Danger Signals in Blood retinal Barrier Activation Poster no. p87 |
12:20
13:15 |
Lunch |
13:15
14:30 |
15th Scientific SessionSymposium: Controversies in Uveitis "Local versus systemic Treatment"
Chairmen: Friederike Mackensen (Heidelberg, Germany)
Russell Read (Birmingham, USA)
supported by
|
82 |
Scleritis: Thomas Albini (Miami, USA) Subconjunctival Triamcinolone |
|
versus |
83 |
Douglas A. Jabs (New York, USA) Systemic Immunosuppression |
84 |
Intraocular Lymphoma: Marc D. de Smet1,2 (1Amsterdam, The Netherlands, 2Antwerp, Belgium) Intravitreal MTX |
|
versus |
85 |
Narsing A. Rao (Los Angeles, USA) Intravenous MTX |
86 |
Chronic uveitic macular Edema: Cristina Muccioli (Sao Paulo, Brazil) Intravitreal Bevacizumab |
|
versus |
87 |
Christoph M. E. Deuter (Tuebingen, Germany) Systemic IFN alpha 2a |
|
Round Table |
14:30
14:45 |
Coffee Break |
14:45
16:00 |
16th Scientific SessionSymposium: Immunopathogenesis of Uveitis
Chairmen: Rachel Caspi (Bethesda, USA)
Jyotirmay Biswas (Chennai, India)
supported by
|
88 |
John V. Forrester (Aberdeen, UK) The Role of Antigen presenting Cells in Uveitis |
89 |
Manabu Mochizukiv (Tokyo, Japan) Role of RPE in regional Immunity in the Eye |
90 |
Graham Wallace (Birmingham, UK) Autoimmune genetic Masterswitches in Uveitis: Autoimmunity or Autoinflammation? |
91 |
Rachel Caspi (Bethesda, USA) Role of Th17 Cells in Uveitis |
92 |
Tammy M. Martin, S.R. Planck, H.L. Rosenzweig, Z. Zhang, E. Lee, D. Spencer, K. Galster, M. Jann, D. Choi, J.T. Rosenbaum (Portland, USA) Homing in Uveitis |
|
Discussion |
16:00
16:15 |
Coffee Break |
16:15
17:45 |
17th Scientific SessionSymposium: Age related Maculopathy = Age related Epitheliitis?
Chairmen: John V. Forrester (Aberdeen, UK)
Robert B. Nussenblatt (Bethesda, USA) |
93 |
Heping Xu (Aberdeen, UK) Inflammatory Pathways in the aging Retina and in age-related retinal Degeneration |
94 |
Paul Morgan (Cardiff, UK) Complement, Complement Regulators and Eye Disease |
95 |
Joe G. Hollyfield (Cleveland, USA) The molecular Link between oxidative Damage and Inflammation in age-related macular Degeneration |
96 |
Chi-Chao Chan, D. Shen, X. Ding, M. Zhou, J. Tuo (Bethesda, USA) Molecular Pathology of AMD: CFH, CX3CR1, and "Epitheliitis" |
97 |
Daniel F. Martin (Atlanta, USA) The Comparison of AMD Treatments Trial (CATT): Lucentis - Avastin Trial |
|
Discussion |
18:15 |
Bus leaves to the IUSG Evening in Bregenz (Austria) |
|
Friday, 12th September 2008 |
08:15
09:30 |
18th Scientific SessionSymposium: New Drugs
Chairmen: Henry J. Kaplan (Louisville, USA)
Annabelle A. Okada (Tokyo, Japan)
supported by
|
98 |
Henry J. Kaplan (Louisville, USA) Target for Drug Therapy in Uveitis in 2008 |
99 |
Talin Barisani-Asenbauer (Vienna, Austria) for the LUMINATE (LX211 Uveitis Multicenter Investigation of a New Approach to Treatment) Uveitis Program Investigator GroupThe new Calcineurin Inhibitors |
100 |
Susan Lightman (London, UK) Posurdex and Uveitis - What do we know? |
100 b |
Kaura Kowalczuk (Paris, France) Electrotransfer for Uveitis |
101 |
Robert B. Nussenblatt (Bethesda, USA) New Drugs for the Future |
|
Round Table |
09:30
09:45 |
Coffee Break |
09:45
11:00 |
19th Scientific SessionSymposium of the American Uveitis Society (AUS) Local Delivery of Drugs
Chairmen: Janet L. Davis (Miami, USA)
John H. Kempen (Philadelphia, USA) |
102 |
John H. Kempen (Philadelphia, USA) Risks of local and systemic Therapy for Uveitis |
103 |
Narsing A. Rao, M. Kumaradas (Los Angeles, USA) Histologic Predictors of local Response |
104 |
Russell Read (Birmingham, USA) Pharmacologic Predictors of local Response |
105 |
Janet L. Davis (Miami, USA) Local Therapy for uveitic Complications |
106 |
Manfred Zierhut (Tuebingen, Germany) Innovations: Topical TNF Inhibitor |
11:00
11:15 |
Coffee Break |
11:15
12:15 |
20th Scientific SessionPoster Session 3 - Therapy
Chairmen: Christoph M. E. Deuter (Tuebingen, Germany)
Yan Guex-Crosier (Lausanne, Switzerland) |
107 |
Carsten Heinz, B. Zurek-Imhoff, J. Koch, M. Rösel, A. Heiligenhaus (Muenster, Germany) Anterior Chamber Flare after cyclodestructive or filtering Surgery in Patients with non-infectious Uveitis and secondary Glaucoma Poster no. p81 |
108 |
Maria Sofia Tognon, A. Sattin, E. Castellani (Padua, Italy) Long term follow-up of Treatment in Tuberculosis Chorioretinitis Poster no. p58 |
109 |
Annabelle A. Okada, H. Keino, T. Watanabe, W. Taki (Tokyo, Japan) Short-term Results on the Use of Infliximab for refractory Uveitis in Behçet's Disease Poster no. p71 |
110 |
Yih-Shiou Hwang, C.-H. Hsiao, S.H.L. Chang, C.-C. Lai (Gueishan, Taiwan) Intravitreal Ganciclovir Injection Followed by Oral Maintenance Valganciclovir for Cytomegalovirus-associated Anterior Uveitis Poster no. p61 |
111 |
Bernhard Noelle (Kiel, Germany) Peripheral multifocal Chorioretinitis - long Term Results with systemic Immunosuppression Poster no. p65 |
112 |
Patricia Udaondo, D. Salom, M. Díaz-Llopis, S. Garcia-Delpech (Valencia, Spain) Adalimumab Therapy for refractory Uveitis Poster no. p91 |
113 |
Bianca Dobner, R. Max, M.D. Becker, F. Mackensen (Heidelberg, Germany) Heidelberg Experience with Adalimumab for the Treatment of non-infectious Uveitis Poster no. p69 |
12:15
13:15 |
Presentations by Membership Candidates for IUSG |
|
Lunch included |
|
Presidential Welcome |
114 |
Sofia Androudi (Thessaloniki, Greece) Outcome of 25-g pars plana Vitrectomy for posterior Segment Disorders in Patients with posterior Uveitis |
115 |
Christoph M. E. Deuter (Tuebingen, Germany) Interferon alfa-2a for the Treatment of chronic cystoid macular Edema in non-infectious Uveitis |
116 |
Sudha K. Ganesh (Chennai, India) Cataract Surgery in Uveitis |
117 |
Nicholas Jones (Manchester, UK) Nurse-led formal Health Review for immunosuppressed Patients with Uveitis |
118 |
Merih B. Soylu (Adana, Turkey) Behçet's Disease in southern Turkey |
13:15
14:30 |
21st Scientific SessionFree Papers 2 - Diagnostic in Uveitis
Chairmen: Petja Vassileva (Sofia, Bulgaria)
Justus G. Garweg (Bern, Switzerland) |
119 |
Padmamalini Mahendradas, R. Shetty, K. Harsha, Bhanumathi, K. Bhujang Shetty (Bangalore, India) Corneal biomechanical Properties in normal , Uveitis, controlled uveitic Glaucoma and uncontrolled uveitic Glaucoma Eyes |
120 |
Lenneke de Visser, A. Rothova. A.M. van Loon, J.D.F. de Groot-Mijnes (Utrecht, The Netherlands) Identification of new Pathogens involved in infectious Uveitis |
121 |
K. Matti Saari, J.M. Saari (Turku, Finland) Structural Changes of the Iris in different Forms of Uveitis studied by infrared Transillumination Imaging |
122 |
Sridharan Sudharshan, G. Balu, B. Mahalakshmi, S.K. Ganesh, H.N. Madhavan, J. Biswas (Chennai, India) Utility of QuantiFERON-TB Gold Test in Diagnosis and Management of suspected tubercular Uveitis in India. |
123 |
Martin Roesel, C. Heinz, A. Henschel, G. Spital, A. Heiligenhaus (Muenster, Germany) Uveitic macular Edema: Association of macular Morphology and visual Acuity. A time and spectral Domain OCT, Fundus-related Microperimetry, and Autofluorescence Study |
124 |
Uwe Pleyer1, J. Johnsen2, L. Shobab2, O. Liesenfeld1, S. Metzner1, M.E. Grigg2 (1Berlin, Germany, 2Bethesda, USA) Clinical Implication of Genotypes in ocular Toxoplasmosis in Germany |
125 |
Justus G. Garweg, S. Morisset, F. Peyron, J.R. Lobry, J.E. Gomez-Marin, A. de la Torre, M.-F. Cesbron-Delauw (Bern, Switzerland) Toxoplasma Strain Serotyping in human ocular Toxoplasmosis |
14:30
14:45 |
Coffee Break |
14:45
15:45 |
22nd Scientific SessionFree Papers 3 - Therapy
Chairmen: Sivakumar R. Rathinam (Madurai, India)
Laure Caspers (Brussels, Belgium) |
126 |
Masoud Soheilian, Z. Rabbanikhah, V. Kiavash, L. Alizadeh Ghavidel, A. Ramezani, H. Ahmadieh, M. Azarmina, M. H. Dehghan, S. Moradian (Tehran, Iran) Intravitreal Bevacizumab versus Triamcinolone Acetonide for refractory cystoid macular Edema in chronic Uveitis: A randomized clinical Trial |
127 |
Amod Gupta, R. Bansal, V. Gupta,P. Bambery, S. Arora (Chandigarh, India) Role of anti-tuberclar Therapy in Uveitis with latent / manifest Tuberculosis |
128 |
Keith J. Wroblewski, S. Yeh, L. Faia, P. Sran, H.N. Sen, R.B. Nussenblatt (Bethesda, USA) Long-term Daclizumab Therapy |
129 |
Amod Gupta, P. Gupta , V. Gupta, R. Singh (Chandigarh, India) Successful Outcome of pars plana vitreous Surgery in chronic Hypotony due to Uveitis |
130 |
Matthias Becker, R. Max, C. Springer, P. Weimer, D. W. Miller, U. Wiehler, B. Storch-Hagenlocher, F. Mackensen (Zurich, Switzerland, Heidelberg, Germany) One Year Results of a randomized controlled clinical Trial comparing Interferon beta with Methotrexate for the Treatment of primary or Multiple Sclerosis-associated intermediate Uveitis with macular Edema |
15:45
16:00 |
Coffee Break |
16:00
17:30 |
IUSG-Business-Meeting |